Rein Therapeutics, Inc.
RNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001420565
No open-market purchases or sales by Rein Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $42.3M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Rein Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +5 vs. Q3 2023
- Shares held
- 1.06M
- +40.5K (+4.0%) vs. Q3 2023
- Total value
- $3.24M
- +$1.69M (+108.6%) vs. Q3 2023
- New holders
- 7
- 4 more added
- Sold out
- 2
- 2 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $42.3M |
| Q1 2026 | 46 | $14.8M |
| Q4 2025 | 48 | $12.5M |
| Q3 2025 | 40 | $9.76M |
| Q2 2025 | 36 | $9.30M |
| Q1 2025 | 39 | $10.6M |
| Q4 2024 | 31 | $13.1M |
| Q3 2024 | 32 | $16.3M |
| Q2 2024 | 29 | $13.5M |
| Q1 2024 | 23 | $11.0M |
| Q4 2023 | 20 | $3.24M |
| Q3 2023 | 16 | $1.59M |
| Q2 2023 | 17 | $1.83M |
| Q1 2023 | 19 | $1.30M |
| Q4 2022 | 19 | $3.21M |
| Q3 2022 | 33 | $5.86M |
| Q2 2022 | 37 | $8.34M |
| Q1 2022 | 42 | $16.5M |
| Q4 2021 | 43 | $18.9M |
| Q3 2021 | 43 | $33.6M |
| Q2 2021 | 47 | $41.5M |
| Q1 2021 | 52 | $48.0M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Rein Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acadian Asset Management LLC | 17 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 27 | $82 | 0.00% | +3+12.5% | Added |
| FMR LLC | 50 | $152 | 0.00% | +50 | New |
| Game Plan Financial Advisors, LLC | 50 | $152 | 0.00% | +50 | New |
| ICA Group Wealth Management, LLC | 100 | $305 | 0.00% | +100 | New |
| Bank of America Corp | 125 | $381 | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 189 | $576 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 1,250 | $3.81K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,250 | $3.81K | 0.00% | 00.0% | Unchanged |
| JFS Wealth Advisors, LLC | 1,590 | $4.85K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,144 | $6.54K | 0.00% | +2,144 | New |
| Tower Research Capital LLC (TRC) | 2,226 | $6.79K | 0.00% | −2,283−50.6% | Reduced |
| Texas Capital Bank Wealth Management Services Inc | 15,773 | $48.1K | 0.01% | +15,773 | New |
| Sigma Planning Corp | 16,580 | $50.5K | 0.00% | +16,580 | New |
| Renaissance Technologies LLC | 28,019 | $85.0K | 0.00% | +9,055+47.7% | Added |
| Blair William & Co | 28,297 | $86.3K | 0.00% | −700−2.4% | Reduced |
| Gagnon Securities LLC | 37,947 | $115.7K | 0.03% | +37,947 | New |
| Vanguard Group Inc | 40,314 | $122.9K | 0.00% | +380+1.0% | Added |
| Geode Capital Management, LLC | 57,288 | $174.2K | 0.00% | +775+1.4% | Added |
| Satter Management Co., L.P. | 830,466 | $2.53M | 3.37% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −20,155−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −19,204−100.0% | Sold out |
| KCK Ltd. | – | – | – | – | Not filed |